Nexgel (NXGL) Income from Non-Controlling Interests (2023 - 2025)
Nexgel posted quarterly Income from Non-Controlling Interests of $42000.0 for Q4 2025, up 61.54% year-on-year from $26000.0 in Q4 2024, and up 600.0% on a QoQ basis from $6000.0 in Q3 2025.
Nexgel (NXGL) has 3 years of Income from Non-Controlling Interests data on file, last reported at $42000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Non-Controlling Interests rose 61.54% year-over-year to $42000.0; the trailing twelve-month figure through Dec 2025 stood at $107000.0 (up 159.12% YoY), and the FY2025 full-year result was $107000.0, up 158.79% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at $42000.0, up from $6000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $53000.0 in Q2 2023 and bottomed at -$94000.0 in Q2 2024.
- The 3-year median for Income from Non-Controlling Interests is $6500.0 (2023), against an average of -$8750.0.
- The widest annual swing landed in 2024, when Income from Non-Controlling Interests slumped 2950.0%; it then jumped 165.38% in 2025.
- A 3-year view of Income from Non-Controlling Interests shows it stood at -$89000.0 in 2023, then soared by 129.21% to $26000.0 in 2024, then soared by 61.54% to $42000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $42000.0 (Q4 2025), $6000.0 (Q3 2025), and $25000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 89,000.00 |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | -61,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -52,000.00 |
| Dec 31, 2023 | -89,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 7,000.00 |